Similar articles

• [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].

  Rapezzi C, Ciliberti P, Graziosi M, Riva L. Rapezzi C, et al. Ital Heart J. 2005 Nov;6 Suppl 7:40S-47S. Ital Heart J. 2005. PMID: 16485516 Review. Italian.
• [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].

  Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L. Magrini G, et al. Ital Heart J. 2005 Nov;6 Suppl 7:14S-23S. Ital Heart J. 2005. PMID: 16485513 Review. Italian.
• [Ischemic heart disease with low risk of vascular complications -- a novel indication for angiotensin converting enzyme inhibitors (results of EUROPA trial)].

  Perepech NB. Perepech NB. Kardiologiia. 2004;44(3):106-10. Kardiologiia. 2004. PMID: 15489840 Review. Russian. No abstract available.
• [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].

  Ferrari R, Ambrosio G, Chiariello M. Ferrari R, et al. Ital Heart J. 2005 Nov;6 Suppl 7:3S-4S. Ital Heart J. 2005. PMID: 16485511 Italian. No abstract available.
• Perindopril and reference antihypertensives.

  Thurston H. Thurston H. S Afr Med J. 1991 Oct 5;Suppl:10-4; discussion 15. S Afr Med J. 1991. PMID: 1925813 Clinical Trial. No abstract available.